FDA approves first nonhormonal treatment for hot flashes associated with...
FDA has approved low-dose paroxetine capsules (Brisdelle, Noven Pharmaceuticals), 7.5 mg/day, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, also...
View ArticleFDA approves first nonhormonal treatment for hot flashes associated with...
FDA has approved low-dose paroxetine capsules (Brisdelle, Noven Pharmaceuticals), 7.5 mg/day, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, also referred...
View ArticleNAMS updates recommendations for vulvovaginal atrophy
Estrogen therapy is still the mainstay of therapy for moderate-to-severe symptoms and long-term studies on endometrial safety of local estrogen and ospemifene are lacking. Those are the key...
View ArticleNew molecular entity
Osphena Ospemifene Shionogi Inc. An estrogen receptor agonist that counteracts the effects of declining estrogen hormones on vaginal tissue, thereby reducing pain during intercourse. On February 26,...
View ArticleFDA approves drug for postmenopausal symptoms
The first drug combining estrogens with bazedoxifene has been approved by the U.S. Food and Drug Administration (FDA) for treatment of moderate-to-severe vasomotor symptoms associated with menopause...
View ArticleA little exercise better than none for overweight postmenopausal women
Overweight and obese postmenopausal women need not be intimidated by customary recommendations for physical activity. A study conducted in Spain and published in the October 2013 issue of the journal...
View Article‘9 Foods That Fight Hot Flashes’
http://www.womansday.com/health-fitness/conditions-diseases/how-to-prevent-hot-flashes#slide-1A study from The American Journal of Clinical Nutrition is the basis for this article in Woman's Day. A...
View ArticleHeavy or prolonged bleeding in menopause is not uncommon
Women undergoing the menopausal transition may be prone to prolonged bleeding with periods of heaviness, according to a new study in BJOG. Women undergoing the menopausal transition may be prone to...
View ArticlePremature menopause associated with risk of lower cognitive function
Early menopause—whether natural or surgical—may be associated with negative effects on cognitive function that are not entirely offset by postmenopausal hormone therapy (HT), according to a new study...
View ArticleEarly menopause tied to heart failure
According to a recent study in Menopause, women who go through natural menopause at ages 40 to 45 may be at increased risk of developing heart failure and smoking may produce a similar risk among...
View ArticleSNRI may be as effective as estrogen for hot flashes
A small study led by investigators from Brigham and Women’s Hospital suggests that the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine hydrochloride may be as effective as low-dose...
View ArticleAromatase inhibitor may improve outcome in premenopausal breast cancer
Adjuvant therapy combining ovarian suppression with an aromatase inhibitor—a class of drugs typically only recommended for postmenopausal patients—may be more beneficial for premenopausal patients...
View ArticleCaffeine may fuel hot flashes
Menopausal hot flashes may be more bothersome in women who drink caffeine, according to results of a 6-year cross-sectional survey published in Menopause. Between July 25, 2005 and July 25, 2011,...
View ArticleWhat’s the impact of hormone therapy on heart health?
According to a recent study in Annals of Internal Medicine, hormonal therapy in early menopause may improve some markers of cardiovascular disease (CVD) risk, but not progression of atherosclerosis....
View ArticleClik here to view.
Ultrasound triage of women with postmenopausal bleeding
Dr. Shwayder is Professor and Chairman, Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson. He reports receiving royalties from Cook Medical for the Goldstein...
View ArticleClik here to view.
Benefits and risks of postmenopausal hormone therapy: Two expert opinions
New options and additional information add perspective By Hugh S. Taylor, MD Dr. Taylor is the Anita O'Keeffe Young Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences,...
View ArticleUntreated hot flashes may impact work productivity
Many women who suffer from moderate to severe vasomotor symptoms (VMS) appear to go untreated, potentially leading to work loss, according to a new study in Menopause. Researchers at Yale School of...
View ArticleClik here to view.
Management of mood and memory problems during menopause
More than 20% of the US population will suffer from an episode of depression, and women have a 2-fold greater risk than men.1 Several large prospective trials have shown an increased risk of depressed...
View ArticleAre severe menopause symptoms a bellwether of bone health?
Women with more severe vasomotor symptoms (VMS) and night sweats may be at risk of having poorer bone health, according to a prospective observational study based on data from the Women’s Health...
View ArticleAre common chemicals associated with earlier onset of menopause?
A study of a representative sample of US women shows a clinically significant association between early menopause and exposure to 15 different endocrine-disrupting chemicals (EDCs) commonly found in...
View Article